Expertise in
8
conditions

Tetsuya Ueda

Tokyo, JP 
Expertise in
8
conditions
Tokyo, JP 

Overview

Tetsuya Ueda practices practicing medicine in Tokyo, Japan.

Mr. Ueda is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Parkes Weber Syndrome, Sturge-Weber Syndrome, Generalized Tonic-Clonic Seizure, and Epilepsy.

He is actively involved in clinical research, co-authoring 101 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Tokyo, Japan
Other Locations
Osaka, Japan
Habikino, Japan
Kyoto, Japan
Fujioka, Japan
Itabashi, Japan
Nerima, 1778521, Japan
Chiba, Japan
Yamanashi, Japan
Higashi-osaka, Japan
Suita, Japan
Gifu-shi, Japan
Ikoma, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3

101 Total Publications

Ictal phase-amplitude coupling supports surgical decision-making in MRI-negative epilepsy with non-localizing SEEG: an illustrative case.
Ictal phase-amplitude coupling supports surgical decision-making in MRI-negative epilepsy with non-localizing SEEG: an illustrative case.
Journal: Acta neurochirurgica
Published: May 12, 2026

Frequently Asked Questions about Tetsuya Ueda

Is Tetsuya Ueda a top-rated expert for Parkes Weber Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Tetsuya Ueda is classified as an Distinguished expert for Parkes Weber Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tetsuya Ueda participate in research or clinical trials?

Yes. Tetsuya Ueda has published 101 articles and abstracts on conditions like Parkes Weber Syndrome. You can view a list of Tetsuya Ueda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ueda's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile